168 related articles for article (PubMed ID: 27814277)
41. Prognostication of OCT4 isoform expression in prostate cancer.
de Resende MF; Chinen LT; Vieira S; Jampietro J; da Fonseca FP; Vassallo J; Campos LC; Guimarães GC; Soares FA; Rocha RM
Tumour Biol; 2013 Oct; 34(5):2665-73. PubMed ID: 23636800
[TBL] [Abstract][Full Text] [Related]
42. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
Liu L; Wu L; Wei X; Ling J
Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
[TBL] [Abstract][Full Text] [Related]
43. Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response.
Wang X; Zhao Y; Xiao Z; Chen B; Wei Z; Wang B; Zhang J; Han J; Gao Y; Li L; Zhao H; Zhao W; Lin H; Dai J
Stem Cells; 2009 Jun; 27(6):1265-75. PubMed ID: 19489092
[TBL] [Abstract][Full Text] [Related]
44. OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer.
Liu T; Sun B; Zhao X; Li Y; Gu Q; Dong X; Liu F
Int J Mol Sci; 2014 Oct; 15(11):19634-49. PubMed ID: 25353179
[TBL] [Abstract][Full Text] [Related]
45. Analysis of Human Stem Cell Transcription Factors.
Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
[TBL] [Abstract][Full Text] [Related]
46. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma.
Ezeh UI; Turek PJ; Reijo RA; Clark AT
Cancer; 2005 Nov; 104(10):2255-65. PubMed ID: 16228988
[TBL] [Abstract][Full Text] [Related]
47. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.
Litviakov NV; Bychkov VA; Stakheeva MN; Ibragimova MK; Tsyganov MM; Gaptulbarova KA; Tashireva LA; Bondar LN; Garbukov EY; Slonimskaya EM
J Mol Histol; 2020 Dec; 51(6):717-728. PubMed ID: 33037978
[TBL] [Abstract][Full Text] [Related]
48. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
49. Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells.
Chang CJ; Chien Y; Lu KH; Chang SC; Chou YC; Huang CS; Chang CH; Chen KH; Chang YL; Tseng LM; Song WS; Wang JJ; Lin JK; Huang PI; Lan YT
Biochem Biophys Res Commun; 2011 Nov; 415(2):245-51. PubMed ID: 22037460
[TBL] [Abstract][Full Text] [Related]
50. OCT4 expression in human uterine myometrial stem/progenitor cells.
Ono M; Kajitani T; Uchida H; Arase T; Oda H; Nishikawa-Uchida S; Masuda H; Nagashima T; Yoshimura Y; Maruyama T
Hum Reprod; 2010 Aug; 25(8):2059-67. PubMed ID: 20576635
[TBL] [Abstract][Full Text] [Related]
51. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells.
Xu G; Yang L; Zhang W; Wei X
Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509
[TBL] [Abstract][Full Text] [Related]
52. Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis.
Villodre ES; Kipper FC; Pereira MB; Lenz G
Cancer Treat Rev; 2016 Dec; 51():1-9. PubMed ID: 27788386
[TBL] [Abstract][Full Text] [Related]
53. Role of OCT4 in cancer stem-like cells and chemotherapy resistance.
Mohiuddin IS; Wei SJ; Kang MH
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165432. PubMed ID: 30904611
[TBL] [Abstract][Full Text] [Related]
54. OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells.
Meng L; Hu H; Zhi H; Liu Y; Shi F; Zhang L; Zhou Y; Lin A
Oncol Lett; 2018 Jul; 16(1):522-528. PubMed ID: 29930717
[TBL] [Abstract][Full Text] [Related]
55. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.
Choi SH; Kim JK; Jeon HY; Eun K; Kim H
Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231
[TBL] [Abstract][Full Text] [Related]
56. Sox2 expression in breast tumours and activation in breast cancer stem cells.
Leis O; Eguiara A; Lopez-Arribillaga E; Alberdi MJ; Hernandez-Garcia S; Elorriaga K; Pandiella A; Rezola R; Martin AG
Oncogene; 2012 Mar; 31(11):1354-65. PubMed ID: 21822303
[TBL] [Abstract][Full Text] [Related]
57. Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma.
Karoubi G; Cortes-Dericks L; Gugger M; Galetta D; Spaggiari L; Schmid RA
J Surg Oncol; 2010 Nov; 102(6):689-98. PubMed ID: 20721963
[TBL] [Abstract][Full Text] [Related]
58. A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors.
Rahmatpanah FB; Jia Z; Chen X; Char JE; Men B; Franke AC; Jones FE; McClelland M; Mercola D
Oncotarget; 2015 Jan; 6(2):1286-301. PubMed ID: 25428913
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of Melatonin Effect on Human Breast Cancer Stem Cells Using a Threedimensional Growth Method of Mammospheres.
Lopes JR; da Silva Kavagutti M; de Medeiros FAF; de Campos Zuccari DAP
Anticancer Agents Med Chem; 2017; 17(7):961-965. PubMed ID: 27671309
[TBL] [Abstract][Full Text] [Related]
60. OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness.
Papamichos SI; Kotoula V; Tarlatzis BC; Agorastos T; Papazisis K; Lambropoulos AF
Mol Hum Reprod; 2009 May; 15(5):269-70. PubMed ID: 19258399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
